Search
Humacyte Inc
HUMAAdd to Watchlist
0.592USD
+0.002+0.34%
Close 11-11 16:00（ET）
164.46MMarket Cap
LossP/E TTM
Pre-market 05:55 (ET)0.590USD-0.002-0.34%
Pre-market 05:55 (ET)Today
+0.34%
5 Days
+31.56%
1 Month
+46.17%
6 Months
-40.80%
Year to Date
-38.40%
1 Year
-53.75%
Key Figures
0.587Open
0.626High
485.74KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.17%Turnover Ratio
0.590Prev. Close
0.554Low
286.68KTurnover
LossP/E Static
5.30P/B
0.00%Div Yield TTM
-71.47%ROA
1.52552wk High
0.07Volume Ratio
-148.70MNet Profit
277.80MShares
-0.6449EPS TTM
2.42Beta
-409.47%ROE
0.33752wk Low
22.20%Amplitude
-262.82%Gross Margin
164.46MMarket Cap
-1.29Reward/Risk
7.24%Risk Rate
Humacyte Inc's Score
-0.07vs previous score
Forecast8.00
Financial Health5.79
Technical6.59
Valuation Dimensions7.70
Institutional Confidence3.00
Risk Assessment2.39
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Humacyte Inc Technical Analysis
Technical Indicators
Neutral
Summary
Buy
Moving Average
Strong buy
Humacyte Inc Latest Earnings Call Transcripts
Humacyte (HUMA) Q2 2026 Earnings Call: Dialysis sBLA Targeted for November
Humacyte’s Q2 2026 earnings call covered $0.4 million in sales, positive V012 dialysis data and a November target for its ATEV sBLA filing.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
--/-0.09
Revenue / Forecast
--/766.00K
Humacyte Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolHUMA
Number of employees218
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Fresenius SE & Co KGaA | 8.25% |
| BlackRock Institutional Trust Company, N.A. | 4.70% |
| Vanguard Capital Management, LLC | 3.22% |
| Antipodes Partners Limited | 2.58% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 16.40% |
| Corporation | 8.25% |
| Investment Advisor/Hedge Fund | 4.86% |
| Hedge Fund | 4.17% |
Related Instruments
+0.35%
-0.13%
+0.37%
-0.59%
-1.80%
-0.69%
+0.62%
-0.67%
+0.96%
+0.31%
-0.16%
+0.18%
-0.26%
+0.41%
-1.23%
-0.85%
+4.73%
-0.43%
+0.24%
+0.62%
FAQs
What is the current price of Humacyte Inc (HUMA)?
The current price of Humacyte Inc (HUMA) is 0.59.
What is the symbol of Humacyte Inc?
The ticker symbol of Humacyte Inc is HUMA.
What is the 52-week high of Humacyte Inc?
The 52-week high of Humacyte Inc is 1.52.
What is the 52-week low of Humacyte Inc?
The 52-week low of Humacyte Inc is 0.34.
What is the market capitalization of Humacyte Inc?
The market capitalization of Humacyte Inc is 164.46M.
Is Humacyte Inc (HUMA) currently rated as Buy, Hold, or Sell?
According to analysts, Humacyte Inc (HUMA) has an overall rating of Buy, with a price target of 1.62.
What is the Earnings Per Share (EPS TTM) of Humacyte Inc (HUMA)?
The Earnings Per Share (EPS TTM) of Humacyte Inc (HUMA) is -0.64.